Diabetes Care Volume 47, Supplement 1, January 2024 S309

Disclosures: Standards of Care in

Diabetes—2024
Diabetes Care 2024;47(Suppl. 1):S309–S313 | https://doi.org/10.2337/dc24-SDIS

Downloaded from http://diabetesjournals.org/care/article-pdf/47/Supplement_1/S309/740368/dc24sdis.pdf by guest on 11 December 2023

Committee members disclosed the following financial or other dualities of interest covering the period 12 months before
December 2023
Other Speakers
Research research bureau/ Ownership Consultant/
Member Employment grant support honoraria interest advisory board Other

DISCLOSURES
American Diabetes Association Professional Practice Committee

Nuha A. ElSayed American Diabetes None None None None None Endocrinologist, Joslin
(Chair)§ Association; Diabetes Center;
Harvard Medical Chair, Diabetes Education
School for All

Grazia Aleppo Northwestern Fractyl,# Insulet,# None None None Dexcom,* Insulet, None
University Feinberg MannKind,# Tandem Medscape
School of Medicine Diabetes Care,#
Division of Welldoc#
Endocrinology,
Metabolism and
Molecular Medicine

Raveendhara R. American Diabetes None None None None None None

Bannuru (Chief Association
Methodologist)§

Dennis Bruemmer Cleveland Clinic Lerner Novartis None None None Bayer,* Esperion* None
College of Medicine,
Case Western Reserve
University

Billy S. Collins Indian Health Service, None None None None None None
Department of Health
and Human Services

Laya Ekhlaspour Division of Abbott,*# Beta Insulet,* MannKind American Diabetes None Diabetes Center Diabetes Technology
Endocrinology, Bionics,*# Insulet,*# Association Bern, Ypsomed, Interest Group
Department of MannKind,*# (honoraria), Icahn Tandem Diabetes (Membership Advisory
Pediatrics, Medtronic,*# Tandem School of Medicine Care Group Liaison); market
University of Diabetes Care*# at Sinai (honoraria), research for health care
California, San Insulet,* Medtronic professionals: online
Francisco (speakers bureau) surveys

Marisa E. Hilliard Baylor College of None None DiabetesMine None None Springer Publishing (book
Medicine Texas (honoraria) royalties); American
Children’s Hospital Diabetes Association
(book royalties)

Eric L. Johnson University of North National Science None American Diabetes None None Member, North Dakota
Dakota School of Foundation# Association Leadership Board;
Medicine and Health (honoraria) Volunteer, Tobacco Free
Sciences; Altru Health North Dakota
System

Continued on p. S310
S310 Disclosures Diabetes Care Volume 47, Supplement 1, January 2024

Other Speakers
Research research bureau/ Ownership Consultant/
Member Employment grant support honoraria interest advisory board Other
Kamlesh Khunti University of AstraZeneca,*# None Amgen, None Amgen, AstraZeneca,* None
Leicester; Boehringer AstraZeneca,* Bayer, Bayer, Berlin-Chemie
Leicester Diabetes Ingelheim,*# Eli Lilly,*# Berlin-Chemie AG/ AG/Menarini Group,
Centre; Leicester Merck Sharp & Menarini Group, Boehringer Ingelheim,*
General Hospital Dohme,*# Novartis,*# Boehringer Eli Lilly,* Merck Sharp
Novo Nordisk,*# Ingelheim,* Eli Lilly,* & Dohme, Napp
Sanofi*# Merck Sharp & Pharmaceuticals,
Dohme, Napp Novartis, Novo
Pharmaceuticals, Nordisk,* Roche,
Novartis, Novo Sanofi, Servier*

Downloaded from http://diabetesjournals.org/care/article-pdf/47/Supplement_1/S309/740368/dc24sdis.pdf by guest on 11 December 2023

Nordisk,* Roche,
Sanofi, Servier*

Ildiko Lingvay Department of Boehringer None Boehringer None Altimmune, Biomea None
Internal Medicine/ Ingelheim,*# Novo Ingelheim,* Eli Lilly,* Fusion, Boehringer
Division of Nordisk,*# Sanofi*# Johnson & Ingelheim,* Carmot
Endocrinology, Johnson,* Novo Therapeutics, Eli Lilly,*
Peter O’Donnell Jr. Nordisk,* Sanofi,* Johnson & Johnson,*
School of Public Zealand Pharma* Merck, Metsera
Health, University Therapeutics, Novo
of Texas Southwestern Nordisk,* Pfizer,
Medical Center Sanofi,* Shionogi,
Structure
Therapeutics, Terns
Pharmaceuticals,
Zealand Pharma*

Glenn Matfin National Health None None None None None None
Service

Rozalina G. McCoy Division of American Diabetes None American Diabetes None None None
Endocrinology, Association* Association
Diabetes, and (honoraria)
Nutrition, University
of Maryland
School of Medicine;
University of
Maryland Institute
for Health
Computing

Mary Lou Perry University of Virginia None None LifeScan Diabetes None Embecta None
Heart and Vascular Institute
Center/Morrison’s
Healthcare

Scott J. Pilla Division of General None None None None None None
Internal Medicine,
Department of
Medicine, Johns
Hopkins University
School of Medicine

Sarit Polsky Barbara Davis Center JDRF,* The Leona H. None None None None Pregnancy Subcommittee
for Diabetes and and Harry B. Helmsley Member, American
University of Charitable Trust,* Diabetes Association
Colorado, Anschutz Dexcom*# 84th Scientific Sessions;
Medical Campus American College of
Diabetology (board
member)

Priya Prahalad Stanford University None None None None None Member of the Epic
Pediatric Endocrinology
Steering Board

Continued on p. S311
diabetesjournals.org/care Disclosures S311

Other Speakers
Research research bureau/ Ownership Consultant/
Member Employment grant support honoraria interest advisory board Other
Richard E. Pratley Advent Health Dompe,# Novo None Novo Nordisk# None Bayer,# Cortcept None
Translational Nordisk,# Rivus Pharmaceuticals,# Eli
Research Institute Pharmaceuticals# Lilly,# Endogenex,#
Gasherbrum Bio,# Intas
Pharmaceuticals,#
Novo Nordisk,#
Pfizer,# Rivus
Pharmaceuticals,#
Sun Pharmaceutical
Industries#

Downloaded from http://diabetesjournals.org/care/article-pdf/47/Supplement_1/S309/740368/dc24sdis.pdf by guest on 11 December 2023

Alissa R. Segal Massachusetts College None None MannKind None None Diabetes Education for All
of Pharmacy & (volunteer board
Health Sciences; member); Diabetes
Brigham and Spectrum, Editorial
Women’s Hospital Board Member

Jane Jeffrie Seley Weill Cornell Medicine None None LifeScan Diabetes None None Director of Strategy,
Institute Diabetes Technology
Society;
Associate Editor,
Diabetes Spectrum;
Editor, Current Diabetes
Reports;
Editor, BMJ Open
Diabetes Research &
Care; Member, ADA
Scientific Sessions
Planning Committee;
Member, ADA Clinical
Update Planning
Committee

Robert C. Stanton Joslin Diabetes None None None None None None
Center, Beth Israel
Deaconess Medical
Center, Harvard
Medical School

Robert A. Gabbay§ American Diabetes None None None None HealthReveal, Lark Joslin Diabetes Center
Association; Technologies,
Harvard Medical Onduo,* StartUp
School Health, Sweetech,
Vida Health*

American College of Cardiology Designated Representatives and Staff (Section 10, “Cardiovascular Disease and Risk Management”)

Sandeep R. Das University of Texas None None None None None American Heart
Southwestern Association (President
Medical Center of the Dallas Board)

Mikhail N. Saint Luke’s Mid American College of None Amgen,*# Astra Artera, Saghmos 35Pharma, Alnylam Senior volunteer, American
Kosiborod America Heart Cardiology Zeneca,*# Bayer,*# Therapeutics Pharmaceuticals,# Heart Association
Institute; Foundation,*# Boehringer Amgen,*# Applied
University of AstraZeneca,*# Ingelheim,*# Therapeutics,#
Missouri–Kansas City Boehringer Medcon AstraZeneca,*#
School of Medicine Ingelheim,*# CPC International, Novo Bayer,*# Boehringer
Clinical Research,*# Nordisk,*# The Ingelheim,*#
Novo Nordisk,*# Metabolic Institute Cytokinetics,#
University of of America, Vifor Dexcom,# Eli Lilly,#
Pittsburgh*# Pharma,*# Vox Esperion
Media Therapeutics,# Imbria
Pharmaceuticals,#

Continued on p. S312
S312 Disclosures Diabetes Care Volume 47, Supplement 1, January 2024

Other Speakers
Research research bureau/ Ownership Consultant/
Member Employment grant support honoraria interest advisory board Other
Janssen
Pharmaceuticals,#
Lexicon
Pharmaceuticals,#
Medscape, Medcon
International, Merck,#
Novo Nordisk,*#
Pharmacosmos,#
Pfizer,*# Radcliffe
Cardiology, Sanofi,#

Downloaded from http://diabetesjournals.org/care/article-pdf/47/Supplement_1/S309/740368/dc24sdis.pdf by guest on 11 December 2023

scPharmaceuticals,#
Structure
Therapeutics,# The
Metabolic Institute of
America, Translational
Medical Academy, Vifor
Pharma,*# Vox Media,
Youngene
Therapeutics#

American Diabetes Association Staff

Elizabeth J. Pekas American Diabetes None None None None None None
Association

Alexandra M. American Diabetes None None None None None None

Yacoubian Association

Designated Subject Matter Experts

Elizabeth A. Beverly Ohio University None None None None None Section Editor, Journal of
Heritage College of Osteopathic Medicine
Osteopathic
Medicine;
Ohio University
Diabetes Institute

Kenneth Cusi University of Florida Echosens,# None None None Bristol-Myers Squibb, None
Inventiva,# Novo GlaxoSmithKline, Lilly,
Nordisk,# Poxel,# Madrigal
Labcorp,*# Boeringer Pharmaceuticals,
Ingelheim,# Quest Merck, Novo Nordisk,
Diagnostics# ProSciento, Quest
Diagnostics, Sagimet
Biosciences, Sonic
Incytes, Terns
Pharmaceuticals

Audrey Darville University of Kentucky None None None None None Association for the
College of Nursing Treatment of Tobacco
Use and Dependence
(Committee Chair)

Talya K. Fleming Hackensack Meridian None None None None NeuroTechR3 None
Health JFK Johnson
Rehabilitation
Institute; Rutgers
Robert Wood
Johnson Medical
School

Jason L. Gaglia Joslin Diabetes Avotres,*# Diamyd None None Vertex Avotres,* Diamyd, None
Center, Harvard Medical,*# Dompe,*# Pharmaceuticals*# Imcyse, Vertex
Medical School Imcyse,*# Sanofi*# Pharmaceuticals*

Continued on p. S313
diabetesjournals.org/care Disclosures S313

Other Speakers
Research research bureau/ Ownership Consultant/
Member Employment grant support honoraria interest advisory board Other
Rodolfo J. Galindo University of Miami Dexcom,# Eli Lilly,# None Eli Lilly* None Abbott, AstraZeneca, American Association of
Miller School of Novo Nordisk# Bayer,* Boehringer Clinical Endocrinology
Medicine Ingelheim, Dexcom, (Author/Member
Eli Lilly,* Novo without compensation
Nordisk for Diabetes Guidelines
2022 and T2D Algorithm
2023);
UptoDate (authorship
royalties)

Christopher H. Beth Israel Deaconess None None None None CND Life Sciences None

Downloaded from http://diabetesjournals.org/care/article-pdf/47/Supplement_1/S309/740368/dc24sdis.pdf by guest on 11 December 2023

Gibbons Medical Center, (scientific advisor)
Harvard Medical
School

John M. Giurini Beth Israel Deaconess None None None None None None
Medical Center

Mohamed Hassanein Dubai Hospital; None None Eli Lilly, Servier None Eli Lilly, Sanofi Chair, Diabetes and
Mohamed Bin-Rashin Ramadan International
University Alliance;
Associate Editor, Dubai
Endocrine

Robert F. Kushner Northwestern None Novo Nordisk None None Altimmune, Editor, Diabetes Care
University Feinberg Boehringer
School of Medicine Ingelheim, Eli Lilly,
Novo Nordisk,*
Weight Watchers*

Lisa Murdock American Diabetes None None None None None None
Association

Nicola Napoli Department of None None None None Boehringer Ingelheim, None
Medicine and Surgery, Eli Lilly, Novo Nordisk
Research Unit of
Endocrinology and
Diabetes, Campus Bio
Medico, University of
Rome; Campus Bio-
Medico University
Hospital Foundation

Elizabeth Selvin Department of American Diabetes None None None None Editor, Diabetes Care;
Epidemiology, Association* NGSP
Johns Hopkins
Bloomberg School of
Public Health; Division
of General Internal
Medicine, Johns
Hopkins School of
Medicine

Paolo S. Silva Beetham Eye Institute, Optos, plc None Roche, Bayer, None Roche, Bayer, None
Joslin Diabetes Center; Boehringer Boehringer Ingelheim
Department of Ingelheim
Ophthalmology,
Harvard Medical School

Monica Verduzco- University of Texas Ipsen Pharma# Ipsen Pharma,* Ipsen Pharma,* None Ipsen Pharma,* None
Gutierrez Health Science Center AbbVie,* Merz AbbVie,* Merz AbbVie,* Merz
at San Antonio Pharmaceuticals* Pharmaceuticals* Pharmaceuticals*

Crystal C. Woodward American Diabetes None None None None None None
Association

Zobair M. Younossi Inova Fairfax Medical None None None None Intercept None
Campus, Inova Health Pharmaceuticals,
System Novo Nordisk, Siemens

*$$10,000 per year from company to individual. #Grant or contract is to university or other employer. §Nuha A. ElSayed, Raveendhara R.
Bannuru, and Robert A. Gabbay are also American Diabetes Association staff.